322 related articles for article (PubMed ID: 30452416)
1. Ceftriaxone Improves Cognitive Function and Upregulates GLT-1-Related Glutamate-Glutamine Cycle in APP/PS1 Mice.
Fan S; Xian X; Li L; Yao X; Hu Y; Zhang M; Li W
J Alzheimers Dis; 2018; 66(4):1731-1743. PubMed ID: 30452416
[TBL] [Abstract][Full Text] [Related]
2. Ceftriaxone regulates glutamate production and vesicular assembly in presynaptic terminals through GLT-1 in APP/PS1 mice.
Fan S; Li L; Xian X; Liu L; Gao J; Li W
Neurobiol Learn Mem; 2021 Sep; 183():107480. PubMed ID: 34153453
[TBL] [Abstract][Full Text] [Related]
3. Ceftriaxone ameliorates hippocampal synapse loss by inhibiting microglial/macrophages activation in glial glutamate transporter-1 dependent manner in the APP/PS1 mouse model of Alzheimer's disease.
Liu LZ; Fan SJ; Gao JX; Li WB; Xian XH
Brain Res Bull; 2023 Aug; 200():110683. PubMed ID: 37301482
[TBL] [Abstract][Full Text] [Related]
4. GLT-1 Knockdown Inhibits Ceftriaxone-Mediated Improvements on Cognitive Deficits, and GLT-1 and xCT Expression and Activity in APP/PS1 AD Mice.
Gao J; Liu L; Liu C; Fan S; Liu L; Liu S; Xian XH; Li WB
Front Aging Neurosci; 2020; 12():580772. PubMed ID: 33132901
[TBL] [Abstract][Full Text] [Related]
5. Ceftriaxone Suppresses Group II Metabotropic Glutamate Receptor Expression Contributing to Reversal of Recognition Memory Deficits of Amyloid Precursor Protein/Presenilin 1 AD Mice.
Fan S; Li L; Liu L; Li H; Xian X; Li W
Front Neurosci; 2022; 16():905403. PubMed ID: 35860293
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological upregulation of GLT-1 alleviates the cognitive impairments in the animal model of temporal lobe epilepsy.
Ramandi D; Elahdadi Salmani M; Moghimi A; Lashkarbolouki T; Fereidoni M
PLoS One; 2021; 16(1):e0246068. PubMed ID: 33507976
[TBL] [Abstract][Full Text] [Related]
7. Ceftriaxone improves impairments in synaptic plasticity and cognitive behavior in APP/PS1 mouse model of Alzheimer's disease by inhibiting extrasynaptic NMDAR-STEP
He RB; Li L; Liu LZ; Ma YJ; Fan SJ; Liu LR; Li WB; Xian XH
J Neurochem; 2023 Jul; 166(2):215-232. PubMed ID: 37284938
[TBL] [Abstract][Full Text] [Related]
8. Ceftriaxone ameliorates tau pathology and cognitive decline via restoration of glial glutamate transporter in a mouse model of Alzheimer's disease.
Zumkehr J; Rodriguez-Ortiz CJ; Cheng D; Kieu Z; Wai T; Hawkins C; Kilian J; Lim SL; Medeiros R; Kitazawa M
Neurobiol Aging; 2015 Jul; 36(7):2260-2271. PubMed ID: 25964214
[TBL] [Abstract][Full Text] [Related]
9. GLT-1 loss accelerates cognitive deficit onset in an Alzheimer's disease animal model.
Mookherjee P; Green PS; Watson GS; Marques MA; Tanaka K; Meeker KD; Meabon JS; Li N; Zhu P; Olson VG; Cook DG
J Alzheimers Dis; 2011; 26(3):447-55. PubMed ID: 21677376
[TBL] [Abstract][Full Text] [Related]
10. CART modulates beta-amyloid metabolism-associated enzymes and attenuates memory deficits in APP/PS1 mice.
Yin K; Jin J; Zhu X; Yu L; Wang S; Qian L; Han L; Xu Y
Neurol Res; 2017 Oct; 39(10):885-894. PubMed ID: 28743230
[TBL] [Abstract][Full Text] [Related]
11. Amalaki Rasayana improved memory and neuronal metabolic activity in AbPP-PS1 mouse model of Alzheimer's disease.
Tiwari V; Saba K; Veeraiah P; Jose J; Lakhotia SC; Patel AB
J Biosci; 2017 Sep; 42(3):363-371. PubMed ID: 29358550
[TBL] [Abstract][Full Text] [Related]
12. Osthole Upregulates BDNF to Enhance Adult Hippocampal Neurogenesis in APP/PS1 Transgenic Mice.
Liu H; Xue X; Shi H; Qi L; Gong D
Biol Pharm Bull; 2015; 38(10):1439-49. PubMed ID: 26424009
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological evaluation of glutamate transporter 1 (GLT-1) mediated neuroprotection following cerebral ischemia/reperfusion injury.
Verma R; Mishra V; Sasmal D; Raghubir R
Eur J Pharmacol; 2010 Jul; 638(1-3):65-71. PubMed ID: 20423712
[TBL] [Abstract][Full Text] [Related]
14. Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer's Disease Assessed in APP/PS1 Transgenic Mice Using
Li XY; Men WW; Zhu H; Lei JF; Zuo FX; Wang ZJ; Zhu ZH; Bao XJ; Wang RZ
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27763550
[TBL] [Abstract][Full Text] [Related]
15. Nitrosylation of Vesicular Transporters in Brain of Amyloid Precursor Protein/Presenilin 1 Double Transgenic Mice.
Wang Y; Zhou Z; Tan H; Zhu S; Wang Y; Sun Y; Li XM; Wang JF
J Alzheimers Dis; 2017; 55(4):1683-1692. PubMed ID: 27911305
[TBL] [Abstract][Full Text] [Related]
16. Ceftriaxone attenuates ethanol drinking and restores extracellular glutamate concentration through normalization of GLT-1 in nucleus accumbens of male alcohol-preferring rats.
Das SC; Yamamoto BK; Hristov AM; Sari Y
Neuropharmacology; 2015 Oct; 97():67-74. PubMed ID: 26002627
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-574 is involved in cognitive impairment in 5-month-old APP/PS1 mice through regulation of neuritin.
Li F; Wei G; Bai Y; Li Y; Huang F; Lin J; Hou Q; Deng R; Zhou JH; Zhang SX; Chen DF
Brain Res; 2015 Nov; 1627():177-88. PubMed ID: 26423933
[TBL] [Abstract][Full Text] [Related]
18. Effective expression of Drebrin in hippocampus improves cognitive function and alleviates lesions of Alzheimer's disease in APP (swe)/PS1 (ΔE9) mice.
Liu Y; Xu YF; Zhang L; Huang L; Yu P; Zhu H; Deng W; Qin C
CNS Neurosci Ther; 2017 Jul; 23(7):590-604. PubMed ID: 28597477
[TBL] [Abstract][Full Text] [Related]
19. Astrocytes and glutamate homoeostasis in Alzheimer's disease: a decrease in glutamine synthetase, but not in glutamate transporter-1, in the prefrontal cortex.
Kulijewicz-Nawrot M; Syková E; Chvátal A; Verkhratsky A; Rodríguez JJ
ASN Neuro; 2013 Oct; 5(4):273-82. PubMed ID: 24059854
[TBL] [Abstract][Full Text] [Related]
20. An anti-nociceptive role for ceftriaxone in chronic neuropathic pain in rats.
Hu Y; Li W; Lu L; Cai J; Xian X; Zhang M; Li Q; Li L
Pain; 2010 Feb; 148(2):284-301. PubMed ID: 20022427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]